These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34207681)

  • 1. Imaging of Substantia Nigra in Parkinson's Disease: A Narrative Review.
    Feraco P; Gagliardo C; La Tona G; Bruno E; D'angelo C; Marrale M; Del Poggio A; Malaguti MC; Geraci L; Baschi R; Petralia B; Midiri M; Monastero R
    Brain Sci; 2021 Jun; 11(6):. PubMed ID: 34207681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.
    Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C
    Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive markers for Parkinson's disease using deep neural nets on neuromelanin sensitive MRI.
    Shinde S; Prasad S; Saboo Y; Kaushick R; Saini J; Pal PK; Ingalhalikar M
    Neuroimage Clin; 2019; 22():101748. PubMed ID: 30870733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
    Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
    Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging evaluation of nigrosome 1 and neuromelanin can assist Parkinson's disease diagnosis, but requires an expert neuroradiologist.
    De Pietro Franco Zorzenon C; Almeida Antônio Bienes GH; Duarte Alves E; Tobaru Tibana LA; Carrete Júnior H; Ballalai Ferraz H
    Parkinsonism Relat Disord; 2021 Feb; 83():8-12. PubMed ID: 33418131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism.
    Pavese N; Tai YF
    Mov Disord Clin Pract; 2018; 5(2):131-140. PubMed ID: 30363419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.
    Hatano T; Okuzumi A; Kamagata K; Daida K; Taniguchi D; Hori M; Yoshino H; Aoki S; Hattori N
    J Neural Transm (Vienna); 2017 Apr; 124(4):407-415. PubMed ID: 28160151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
    Wang C; Fan G; Xu K; Wang S
    Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Saeed U; Lang AE; Masellis M
    Front Neurol; 2020; 11():572976. PubMed ID: 33178113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.
    Simões RM; Castro Caldas A; Grilo J; Correia D; Guerreiro C; Pita Lobo P; Valadas A; Fabbri M; Correia Guedes L; Coelho M; Rosa MM; Ferreira JJ; Reimão S
    BMC Neurol; 2020 Nov; 20(1):432. PubMed ID: 33243166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nigrosome and Neuromelanin Imaging as Tools to Differentiate Parkinson's Disease and Parkinsonism.
    Biswas D; Banerjee R; Sarkar S; Choudhury S; Sanyal P; Tiwari M; Kumar H
    Ann Indian Acad Neurol; 2022; 25(6):1029-1035. PubMed ID: 36911494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of the combined use of
    Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
    Acta Radiol; 2019 Feb; 60(2):230-238. PubMed ID: 29804474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromelanin-sensitive MRI correlates of cognitive and motor function in Parkinson's disease with freezing of gait.
    Huddleston DE; Chen X; Hwang K; Langley J; Tripathi R; Tucker K; McKay JL; Hu X; Factor SA
    medRxiv; 2023 Jul; ():. PubMed ID: 37461735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern Brainstem MRI Techniques for the Diagnosis of Parkinson's Disease and Parkinsonisms.
    Arribarat G; De Barros A; Péran P
    Front Neurol; 2020; 11():791. PubMed ID: 32849237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging markers for early diagnosis of Parkinson's disease.
    Marino S; Ciurleo R; Di Lorenzo G; Barresi M; De Salvo S; Giacoppo S; Bramanti A; Lanzafame P; Bramanti P
    Neural Regen Res; 2012 Mar; 7(8):611-9. PubMed ID: 25745453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta.
    Langley J; Huddleston DE; Sedlacik J; Boelmans K; Hu XP
    Mov Disord; 2017 Mar; 32(3):441-449. PubMed ID: 28004859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromelanin or DaT-SPECT: which is the better marker for discriminating advanced Parkinson's disease?
    Okuzumi A; Hatano T; Kamagata K; Hori M; Mori A; Oji Y; Taniguchi D; Daida K; Shimo Y; Yanagisawa N; Nojiri S; Aoki S; Hattori N
    Eur J Neurol; 2019 Nov; 26(11):1408-1416. PubMed ID: 31136060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.
    Xiang Y; Gong T; Wu J; Li J; Chen Y; Wang Y; Li S; Cong L; Lin Y; Han Y; Yin L; Wang G; Du Y
    Neurosci Lett; 2017 Jan; 638():145-150. PubMed ID: 27993708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
    Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
    Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging.
    Ohtsuka C; Sasaki M; Konno K; Kato K; Takahashi J; Yamashita F; Terayama Y
    Parkinsonism Relat Disord; 2014 Jul; 20(7):755-60. PubMed ID: 24768616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.